TMCnet News
Research and Markets: Global Schizophrenia (First and Second Generation) Therapeutics Market 2014-2018: Increase in Generic CompetitionDUBLIN --(Business Wire)-- Research and Markets (http://www.researchandmarkets.com/research/f4jkpw/global) has announced the addition of the "Global Schizophrenia Therapeutics Market 2014-2018" report to their offering. The Global Schizophrenia Therapeutics market to grow at a CAGR of 2.82% over the period 2013-2018 One major trend in this market is the increase in the awareness of schizophrenia. The awareness among patients and physicians is expected to increase the penetration of drugs in the market. According to the report, an increase in the aging population worldwide is one of the main drivers of the market. Aging is one of the main causes of CNS disorders, including schizophrenia. Therefore, the global burden of the disorder is increasing because of the rapidly aging populationin different parts of the world. Further, the report states that an increase in the generic competition is one of the main challenges that the market confronts. The availability of low-cost generic drugs intensifies the competition among the vendors and thus substantially reduces the cost of patented/branded drugs. The Global Schizophrenia Therapeutics market can be segmented into two:
Key Vendors
Key Topics Covered:
For more information visit http://www.researchandmarkets.com/research/f4jkpw/global.
|